Metraipolis › archive › dc_01ec8986b382
Fragment-Based Drug Discovery of Novel High-affinity, Selective, and Anti-inflammatory Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction — Europe PMC PMID:40838516
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40838516
- DOI
- 10.1002/anie.202508121
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T10:46:18.083Z
- SHA-256 of the archived text
bb17ebf03fbec1efaa1ebab3dd8a0294fc97610577cc6b4e36cd21e258511ef6- Stable URL of this page
https://metraipolis.com/documento/dc_01ec8986b382
How to cite
Fragment-Based Drug Discovery of Novel High-affinity, Selective, and Anti-inflammatory Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction — Europe PMC PMID:40838516 — Europe PMC (en), https://europepmc.org/article/MED/40838516 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_01ec8986b382 (Metraipolis archive dc_01ec8986b382, sha256 bb17ebf03fbec1efaa1ebab3dd8a0294fc97610577cc6b4e36cd21e258511ef6)
BibTeX
@misc{dc01ec8986b382,
title = {Fragment-Based Drug Discovery of Novel High-affinity, Selective, and Anti-inflammatory Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction — Europe PMC PMID:40838516},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40838516},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_01ec8986b382; sha256 bb17ebf03fbec1efaa1ebab3dd8a0294fc97610577cc6b4e36cd21e258511ef6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40838516. Agents can read the archived copy with the MCP tool read_document.